Tag
fda
-
Skepticism is required when covering the science behind genetic tests
Health insurers struggle to understand whether genetic tests give physicians actionable information about how to diagnose and treat patients’ illness.…
-
Gene therapy development on the rise but costs remain an issue
After decades of unfulfilled promises and setbacks, the field of gene therapy broke through with three FDA-approved products last year,…
-
Putting a human face on new antimicrobial research
A desire to put a human face to antibiotic resistance led reporter Chris Dall to dig into the relatively unknown…
-
Draft guidance signals FDA seeks to foster innovation in digital health sector
The FDA’s new guidance on digital health paves way for more tools that aim to support physicians and patients. Expect…
-
•
Medical ethicist discusses Right-to-Try legislation
Taken at face value, Right-to-Try (RTT) legislation sounds like a no-brainer, promising to improve access to treatments yet unapproved for…
-
How often do drugs obtaining accelerated approval fulfill their potential?
If a new drug appears to show remarkable success in curing patients with a specific, aggressive cancer type that has…
-
Study suggests FDA medical device approvals ripe for investigative dives
Medical devices — and the unrecognized or undisclosed risks some of them have — have been in the news quite…
-
FDA moves on digital health innovation
Last week’s blog post by Food and Drug Administration Commissioner Scott Gottlieb, M.D., is providing digital health innovators with a…
-
What’s next for drug costs? #AHCJ17 hears from the experts – including a patient
President Donald Trump has spoken about the cost of drugs frequently. Though not always clearly and consistently, he has called…
-
•
FDA bans ‘close-hold embargoes’ in response to AHCJ protest
The Food and Drug Administration has banned a communications practice that troubled journalists and sparked protests from AHCJ and others.…
